| Net Cash Provided by (Used in) Operating Activities |
-455K |
USD |
+11.3% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
470K |
USD |
+6.61% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
21K |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
400M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
92.4M |
shares |
+65.6% |
Q2 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
36K |
USD |
|
Q3 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.78M |
USD |
+1042% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
6.76M |
USD |
+20.9% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
6.76M |
USD |
+20.9% |
Q2 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-3.26M |
USD |
+8.56% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
5.7M |
USD |
+8.91% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
36.8M |
USD |
+12.6% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
232K |
USD |
-24.2% |
Q2 2025 |
FY 2025 |